It also revealed that YAP canonical targets such as CTGF (connective tissue growth factor) or CYR61 (cysteine rich angiogenic inducer 61) do not show significant changes in their expression with respect to tumor grade or stage [54] (Table 1). The gene discussed is YAP1; the disease is neoplasm.